X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10100) 10100
Publication (305) 305
Newsletter (235) 235
Book Review (70) 70
Book Chapter (30) 30
Magazine Article (30) 30
Newspaper Article (21) 21
Conference Proceeding (18) 18
Dissertation (10) 10
Book / eBook (4) 4
Transcript (4) 4
Report (3) 3
Data Set (2) 2
Web Resource (2) 2
Journal / eJournal (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6265) 6265
female (5249) 5249
bromocriptine (4290) 4290
male (4028) 4028
bromocriptine - therapeutic use (3680) 3680
adult (3174) 3174
bromocriptine - pharmacology (2775) 2775
animals (2617) 2617
middle aged (2050) 2050
prolactin - blood (2033) 2033
rats (1676) 1676
pregnancy (1554) 1554
endocrinology & metabolism (1110) 1110
aged (1083) 1083
prolactin (1056) 1056
pituitary neoplasms - drug therapy (902) 902
bromocriptine - administration & dosage (876) 876
parkinson disease - drug therapy (853) 853
bromocriptine - adverse effects (843) 843
index medicus (797) 797
dopamine (789) 789
clinical neurology (778) 778
pharmacology & pharmacy (767) 767
neurosciences (733) 733
adolescent (714) 714
dopamine agonists - therapeutic use (659) 659
time factors (657) 657
prolactin - secretion (563) 563
dose-response relationship, drug (551) 551
hyperprolactinemia (537) 537
prolactin - metabolism (537) 537
ergolines - therapeutic use (509) 509
rats, inbred strains (480) 480
drug therapy, combination (463) 463
levodopa - therapeutic use (460) 460
dopamine agonists - pharmacology (453) 453
cabergoline (447) 447
prolactinoma - drug therapy (445) 445
mice (431) 431
treatment outcome (417) 417
prolactinoma (411) 411
parkinson's disease (405) 405
receptors, dopamine - drug effects (401) 401
therapy (398) 398
psychiatry (392) 392
pituitary neoplasms - complications (383) 383
dopamine agonists (382) 382
hyperprolactinemia - drug therapy (366) 366
pituitary neoplasms - pathology (366) 366
double-blind method (365) 365
pituitary neoplasms - metabolism (360) 360
growth hormone - blood (357) 357
medicine, general & internal (356) 356
luteinizing hormone - blood (352) 352
acromegaly - drug therapy (350) 350
pituitary neoplasms - surgery (325) 325
levodopa (324) 324
dopamine - physiology (314) 314
adenoma - drug therapy (313) 313
pituitary neoplasms - secretion (313) 313
ergolines - pharmacology (312) 312
lactation - drug effects (307) 307
follicle stimulating hormone - blood (298) 298
clinical trials as topic (294) 294
antiparkinson agents - therapeutic use (291) 291
research (283) 283
magnetic resonance imaging (282) 282
amenorrhea - drug therapy (280) 280
prolactin - physiology (276) 276
follow-up studies (262) 262
pituitary neoplasms - blood (261) 261
prolactin - antagonists & inhibitors (249) 249
surgery (248) 248
prolactin - pharmacology (244) 244
tumors (242) 242
secretion (241) 241
pituitary neoplasms - diagnosis (238) 238
parkinsons-disease (231) 231
apomorphine - pharmacology (230) 230
haloperidol - pharmacology (230) 230
infertility, female - drug therapy (230) 230
lactation (229) 229
pergolide (229) 229
levodopa - adverse effects (228) 228
dopamine - pharmacology (224) 224
rats, wistar (223) 223
dopamine agonist (221) 221
medicine & public health (219) 219
obstetrics & gynecology (219) 219
receptors (218) 218
pituitary neoplasms - therapy (216) 216
progesterone - blood (214) 214
dopamine agonists - adverse effects (212) 212
double-blind (210) 210
rats, sprague-dawley (209) 209
management (208) 208
tomography, x-ray computed (208) 208
women (208) 208
retrospective studies (207) 207
kinetics (204) 204
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8850) 8850
French (357) 357
German (283) 283
Japanese (216) 216
Spanish (167) 167
Russian (157) 157
Italian (116) 116
Polish (60) 60
Chinese (35) 35
Dutch (26) 26
Portuguese (23) 23
Bulgarian (22) 22
Czech (19) 19
Hungarian (19) 19
Danish (17) 17
Korean (15) 15
Swedish (15) 15
Hebrew (9) 9
Croatian (7) 7
Norwegian (6) 6
Finnish (5) 5
Persian (4) 4
Romanian (4) 4
Serbian (3) 3
Turkish (3) 3
Ukrainian (3) 3
Lithuanian (2) 2
Macedonian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Kang, Y and Kim, S.J and Min, J
Ultrasound in Obstetrics & Gynecology, ISSN 0960-7692, 09/2014, Volume 44, Issue S1, pp. 367 - 367
Journal Article
WHO Drug Information, ISSN 1010-9609, 06/2014, Volume 28, Issue 3, p. 324
Journal Article
European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 02/2013, Volume 48, Issue 3, pp. 393 - 405
Graphical abstract showing biodistribution studies on organ of interest of different formulations administered by different routes (a) bromocriptine (BRC)... 
Nanoparticles | Parkinson disease | Chitosan | Haloperidol | Bromocriptine | Biodistribution study | SYSTEM | DRUG-DELIVERY | TARGETING EFFICIENCY | INTRANASAL DELIVERY | FORMULATION | IN-VIVO | PHARMACOLOGY & PHARMACY | OLANZAPINE | PLGA NANOPARTICLES | PARKINSONS-DISEASE | BLOOD | Catalepsy - etiology | Brain - diagnostic imaging | Bromocriptine - administration & dosage | Injections, Intravenous | Nanoparticles - chemistry | Catalepsy - prevention & control | Male | Parkinson Disease - drug therapy | Hypokinesia - etiology | Bromocriptine - metabolism | Bromocriptine - therapeutic use | Drug Delivery Systems | Antiparkinson Agents - therapeutic use | Brain - metabolism | Tissue Distribution | Sodium Pertechnetate Tc 99m | Bromocriptine - pharmacokinetics | Drug Compounding | Behavior, Animal - drug effects | Neurons - metabolism | Parkinson Disease - metabolism | Neurons - drug effects | Disease Models, Animal | Hypokinesia - prevention & control | Parkinson Disease - diagnostic imaging | Random Allocation | Parkinson Disease - physiopathology | Administration, Intranasal | Blood-Brain Barrier - drug effects | Antiparkinson Agents - pharmacokinetics | Brain - drug effects | Neurons - diagnostic imaging | Animals | Chitosan - chemistry | Radionuclide Imaging | Antiparkinson Agents - administration & dosage | Mice | Antiparkinson Agents - metabolism | Brain | Central nervous system depressants
Journal Article
Effects of Bromocriptine on Negative Symptoms of Schizophrenia: A Double Blind Clinical Trial, 12/2002
Negative symptoms are still a major obstacle in the recovery of schizophrenic patients. Many attempts to develop novel drugs affecting negative symptoms of... 
schizophrenia, negative symptoms, dopamine agonist, bromocriptine
Journal
Journal Article
European journal of endocrinology, ISSN 0804-4643, 08/2018, Volume 179, Issue 2, pp. R69 - R75
Journal Article
Gynecologie Obstetrique & Fertilite, ISSN 1297-9589, 03/2007, Volume 35, Issue 3, p. 224
L'association maladie de Parkinson et grossesse est tres rare, avec une trentaine de cas repertoriee dans la litterature. Nous rapportons le cas d'une... 
Bromocriptine
Journal Article
Journal Article
BJOG: An International Journal of Obstetrics & Gynaecology, ISSN 1470-0328, 08/2015, Volume 122, Issue 9, pp. 1244 - 1251
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 7/2008, Volume 25, Issue 7, pp. 1521 - 1530
The present investigation describes a formulative study for the development of innovative drug delivery systems for bromocriptine.Solid lipid nanoparticles... 
Biomedical Engineering | Biochemistry, general | bromocriptine (BK) | Biomedicine | Pharmacy | nanostructured lipid carrier (NLC) | photon correlation spectroscopy (PCS) | Medical Law | cryo transmission electron microscopy | solid lipid nanoparticles (SLN) | Pharmacology/Toxicology | bar test | Cryo transmission electron microscopy | Bromocriptine (BK) | Solid lipid nanoparticles (SLN) | Bar test | Photon correlation spectroscopy (PCS) | Nanostructured lipid carrier (NLC) | DRUG-DELIVERY | BLOOD-BRAIN-BARRIER | CARRIERS | CHEMISTRY, MULTIDISCIPLINARY | RECOVERY | SLN | L-DOPA | BODY DISTRIBUTION | PHARMACOLOGY & PHARMACY | MOTOR COMPLICATIONS | PARKINSONS-DISEASE | CORRELATION SPECTROSCOPY | Bromocriptine - administration & dosage | Lipids | Male | Chromatography, High Pressure Liquid | Oxidopamine | Bromocriptine - therapeutic use | Drug Delivery Systems | Antiparkinson Agents - therapeutic use | Nanoparticles | X-Ray Diffraction | Light | Parkinson Disease, Secondary - drug therapy | Behavior, Animal - drug effects | Scattering, Radiation | Parkinson Disease, Secondary - chemically induced | Rats | Triglycerides | Microscopy, Electron | Absorptiometry, Photon | Rats, Sprague-Dawley | Spectrophotometry, Ultraviolet | Cryoelectron Microscopy | Animals | Antiparkinson Agents - administration & dosage | Dialysis | Kinetics | Bromocriptine | Nanotechnology | Prescription drugs | Pharmacology | Parkinsons disease | Index Medicus
Journal Article
07/2008
Objective: There are relatively few reports in the world comparing the beneficial and adverse effects of bromocriptine and cabergoline in the treatment of... 
Hyperprolactinemia, amenorrhea, galactorrhea, bromocriptine, cabergoline
Web Resource
Antiviral Research, ISSN 0166-3542, 05/2017, Volume 141, pp. 29 - 37
Journal Article